Secretion of extracellular matrix‐degrading proteinases is increased in epithelial ovarian carcinoma

International Journal of Cancer

Volumn 56, Issue 4, 1994, Pages 552-559

  Moser, Tammy L ^a   Young, Timothy N ^a   Rodriguez, Gustavo C ^a   Pizzo, Salvatore V ^a   Bast, Robert C ^a   Stack, M Sharon ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR CELL LINE;

BLOTTING, WESTERN; CULTURE MEDIA, CONDITIONED; ENDOPEPTIDASES; EPITHELIUM; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMAN; METALLOENDOPEPTIDASES; OVARIAN NEOPLASMS; OVARY; PLASMIN; PLASMINOGEN; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE PLASMINOGEN ACTIVATOR; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0028280052     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910560415     Document Type: Article

References (30)

1. Tumor cell invasion inhibited by TIMP‐2
2. Reactivity of a monoclonal antibody with human ovarian carcinomas
3. Carcinoma of the ovary: a clinicopathological study of 86 autopsied cases with special reference to mode of spread
4. Plasminogen activation by t‐PA on the surface of human melanoma cells in the presence of alpha‐2‐macroglobulin secretion
5. Isolation and interrelationships of the multiple molecular tissue‐type and urokinase‐type plasminogen activator forms produced by cultured human umbilical vein endothelial cells
6. Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells
7. Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix
8. Plasminogen activators, tissue degradation and cancer
9. In vitro biosynthesis of plasminogen in a cell‐free system directed by mRNA fractions isolated from monkey liver
10. Crosslinked fibrin derivatives and fibronectin in ascitic fluid from patients with ovarian cancer compared to ascitic fluid in liver cirrhosis
11. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
12. Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR‐3) with a reconstituted basement membrane (Matrigel)
13. Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro
14. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase‐type plasminogen activator and cathepsin B
15. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
16. Biochemical interactions of tumor cells with the basement membrane
17. Plasminogen receptors: ubiquitous sites for cellular regulation of fibrinolysis
18. The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes
19. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
20. In vitro degradation of extracellular matrix by human ovarian carcinoma cells
21. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties
22. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components
23. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
24. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. Relationship between receptor expression and response to epidermal growth factor
25. Inhibition of proteolytic enzymes
26. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide
27. Modulation of murine B16F10 plasminogen activator production by a synthetic peptide derived from the laminin A chain
28. Proteolytic degradation of extracellular matrix in tumor invasion
29. Gelatinases of murine metastatic tumor cells